<PAGE>



                         SECURITIES EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                            ------------------------

                                    FORM 40-F

/ /              REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE
                        SECURITIES EXCHANGE ACT OF 1934

/X/       ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES
                              EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2003     Commission File Number 000-20390

                            ------------------------

                            ID BIOMEDICAL CORPORATION
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

<TABLE>
<CAPTION>
<S>                                       <C>                                <C>
          BRITISH COLUMBIA                            6794                     NOT APPLICABLE
   (PROVINCE OF OTHER JURISDICTION        (PRIMARY STANDARD INDUSTRIAL        (I.R.S. EMPLOYER
  OF INCORPORATION OR ORGANIZATION)       CLASSIFICATION CODE NUMBER)        IDENTIFICATION NO.)
</TABLE>

                             1630 WATERFRONT CENTER
                               200 BURRARD STREET
                           VANCOUVER, BRITISH COLUMBIA
                         CANADA, V6C 3L6, (604) 431-9314
   (ADDRESS AND TELEPHONE NUMBER OF REGISTRANTS' PRINCIPAL EXECUTIVE OFFICES)

                     ID BIOMEDICAL CORPORATION OF WASHINGTON
               19204 NORTH CREEK PARKWAY, SUITE 100 BOTHELL 98011
                                 (425) 482-2601
            (NAME, ADDRESS (INCLUDING ZIP CODE) AND TELEPHONE NUMBER
        (INCLUDING AREA CODE) OF AGENT FOR SERVICE IN THE UNITED STATES)

                   ------------------------------------------

Securities registered or to be registered pursuant to Section 12(b) of the Act:

                                      None

Securities registered or to be registered pursuant to Section 12(g) of the Act:

<TABLE>
<CAPTION>
TITLE OF EACH CLASS:                NAME OF EACH EXCHANGE ON WHICH REGISTERED:
--------------------                ------------------------------------------
<S>                                 <C>
Common Shares,                               The Toronto Stock Exchange
without par value                            The Nasdaq Stock Market
</TABLE>

 Securities for which there is a reporting obligation pursuant to Section 15(d)
                                  of the Act:

                                      None

For annual reports, indicate by check mark the information filed with this Form:

    /X/ Annual information form     /X/ Audited annual financial statements

Indicate the number of outstanding shares of each of the issuer's classes of
capital or common stock as of the close of the period covered by this annual
report.

                      The Registrant had 41,944,847 shares
                        outstanding at December 31, 2003

Indicate by check mark whether the Registrant by filing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934
(the "Exchange Act"). If "Yes" is marked, indicate the filing number assigned to
the registrant in connection with such rule.

                          Yes ___ 82-____       No X
                                                  ---

Indicate by check mark whether the Registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Exchange Act during the
preceding 12 months (or for such shorter period that the Registrant was required
to file such reports); and (2) has been subject to such filing requirements for
the past 90 days.
                          Yes X                 No ___
                             ---



<PAGE>


                                TABLE OF CONTENTS


                                                                  Page Number
Principal Documents                                                     1

Controls and Procedures                                                 1

Audit Committee Financial Expert                                        1

Code of Ethics                                                          1

Principal Accountant Fees and Services                                  2

Pre-Approval Policies                                                   2

Off-Balance Sheet Arrangements                                          2

Disclosure of Contractual Obligations                                   2

Identification of Audit Committee                                       3

Undertaking and Consent to Service of Process                           3


                                    EXHIBITS

<TABLE>
<CAPTION>
EXHIBIT                           DESCRIPTION
-------  -----------------------------------------------------------------------
<S>      <C>
1        Annual Information Form of the Registrant for the fiscal year ended
         December 31, 2003.

2        Consolidated Audited Financial Statements of the Registrant for the
         year ended December 31, 2003, including a reconciliation to United
         States generally accepted accounting principles and Auditors' Report to
         the Shareholders.

3        Management's Discussion and Analysis of the Registrant for the year
         ended December 31, 2003.

4        Code of Ethics.

5        Consent of KPMG LLP.

6.1      Certifications of Chief Executive Officer pursuant to Rule 13a-14(b)
         and Section 1350 of Chapter 63 of Title 18 of the United States Code
         (18 U.S.C. 1350).

6.2      Certifications of Principal Financial Officer pursuant to
         Rule 13a-14(b) and Section 1350 of Chapter 63 of Title 18 of the
         United States Code (18 U.S.C. 1350).
</TABLE>


<PAGE>


Except where otherwise indicated, all dollar amounts stated in this Annual
Report on Form 40-F are Canadian dollars.

PRINCIPAL DOCUMENTS

    The following documents have been filed as part of this Annual Report on
Form 40-F:

A.   ANNUAL INFORMATION FORM

    For our Annual Information Form for the year ended December 31, 2003, see
Exhibit 1 of this Annual Report on Form 40-F.

 B.  AUDITED ANNUAL FINANCIAL STATEMENTS

    For our consolidated audited financial statements for the year ended
December 31, 2003, including the report of independent chartered accountants
with respect thereto, see Exhibit 2 of this Annual Report on Form 40-F. For a
reconciliation of important differences between Canadian and United States
generally accepted accounting principles, see Note 21 of the Notes to the
Consolidated Financial Statements.

C.   MANAGEMENT'S DISCUSSION AND ANALYSIS

    For Management's Discussion and Analysis for the year ended December 31,
2003, see Exhibit 3 of this Annual Report on Form 40-F.

CONTROLS AND PROCEDURES

 A.  DISCLOSURE CONTROLS AND PROCEDURES

    Within 90 days prior to the date of this report we carried out an
evaluation, under the supervision and with the participation of our Chief
Executive Officer and Principal Financial Officer, of the effectiveness of the
design and operation of our disclosure controls. Based on this evaluation, the
Chief Executive Officer and Principal Financial Officer concluded, that our
disclosure controls and procedures are effective in timely alerting them to
material information required to be included in our periodic SEC reports. It
should be noted that the design of any system of control is based in part on
certain assumptions about the likelihood of future events and there can be no
assurance that any design will succeed in achieving its stated goals under all
potential future conditions, regardless of how remote.

 B.  CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING

    We have reviewed our internal controls, and there were no significant
changes to our internal controls or in other factors that could significantly
affect those controls subsequent to the date of their last evaluation, including
any corrective actions with regard to significant deficiencies and material
weaknesses.

AUDIT COMMITTEE FINANCIAL EXPERT

    Our board of directors has determined that Richard H. McCoy is an audit
committee financial expert serving on its audit committee (as defined in
paragraph 8(b) of General Instruction B to Form 40-F). For a description of Mr.
McCoy's relevant experience in financial matters, see Mr. McCoy's employment
history in the section "Directors and Officers" in the Registrant's Annual
Information Form for the year ended December 31, 2003, which is filed as Exhibit
1 to this Annual Report on Form 40-F.

CODE OF ETHICS

     Our code of ethics applicable to our principal executive officer, principal
financial officer, principal accounting officer or controller or persons
performing similar functions is disclosed in our Code of Ethics, which is filed
as Exhibit 4 to this Annual Report on Form 40-F. In the event that we:

     (i)  amend any provision of our Code of Ethics that applies to our
          principal executive officer, principal financial officer, principal
          accounting officer or controller or persons performing similar
          functions that relates to any element of the code of ethics definition
          enumerated in paragraph (9)(b) of General Instruction B to Form 40-F,
          or


                                         1

<PAGE>

     (ii) grant a waiver, including an implicit waiver, from a provision of our
          Code of Ethics to any of our principal executive officer, principal
          financial officer, principal accounting officer or controller or
          persons performing similar functions that relates to any element of
          the code of ethics definition as enumerated in paragraph (9)(b) of
          General Instruction B to Form 40-F

we will disclose in a Form 6-K any amendment to, or waiver of, a provision of
our Code of Ethics that relates to the items set forth above. Such disclosure
will specifically describe the nature of the amendment or waiver, and will, in
the case of a waiver, name the person to whom the waiver was granted.

PRINCIPAL ACCOUNTANT FEES AND SERVICES

     The following table provides information about the fees billed to us for
professional services rendered by KPMG LLP, our principal accountants, during
fiscal 2003 and 2002, respectively:


<TABLE>
<CAPTION>
                                                             AGGREGATE FEES BILLED BY THE
                                                                 PRINCIPAL ACCOUNTANT
                                                           ---------------------------------
                                                             2003                      2002
                                                           -------                   -------
                                                                     ($ thousands)
<S>                                                        <C>                       <C>
     Audit fees                                            328,113                   123,000
     Audit-related fees                                     24,786                      -
     Tax fees                                               74,100                    35,000
     All other fees                                           -                       98,350
     Total Fees                                            426,999                   256,350
</TABLE>


For the year ended December 31, 2003, the total amount of fees paid by the
Company to KPMG LLP for professional services rendered was $426,999. These fees
were paid as follows:

AUDIT FEES. Audit fees consist of fees for the audit of our annual financial
statements or services that are normally provided in connection with statutory
and regulatory filings or engagements. The Company paid KPMG LLP a total of
$140,000 for audit services in connection with the audit of the Company's annual
consolidated financial statements for the year ended December 31, 2002 and the
review of the Company's quarterly consolidated financial statements for 2003.
The Company paid $188,113 for audit services in connection with financing
activities.

AUDIT-RELATED FEES. The Company paid KPMG LLP a total of $24,786 for audit
related services rendered during the year ended December 31, 2003 consisting of
consultation on accounting issues.

TAX FEES. Tax fees of $74,100 included tax compliance, tax planning, tax advice
and various taxation matters.

ALL OTHER FEES.  N/A


PRE-APPROVAL POLICIES

Since the enactment of the Sarbanes-Oxley Act of 2002 on July 30, 2002, all
audit and non-audit services performed by the Registrant's auditor for the
fiscal year ended December 31, 2003 were pre-approved by the audit committee of
the Registrant. See the section entitled "Charter of the Audit Committee" in the
Registrant's Annual Information Form for the year ended December 31, 2003, which
is filed as Exhibit 1 to this Annual Report on Form 40-F.


OFF-BALANCE SHEET ARRANGEMENTS

     The Registrant has no off-balance sheet arrangements to report. See the
section entitled "Off Balance Sheet Transactions and Contractual Commitments" in
the Registrant's Annual Information Form for the year ended December 31, 2003,
which is filed as Exhibit 1 to this Annual Report on Form 40-F.

DISCLOSURE OF CONTRACTUAL OBLIGATIONS

     In the normal course of business, the Registrant is obligated to make
future payments. These obligations


                                         2

<PAGE>

represent contracts and other commitments that are known and non-cancelable.

<TABLE>
<CAPTION>
                                                                  CONTRACTUAL OBLIGATIONS
                                                                   PAYMENT DUE BY PERIOD
                                           --------------------------------------------------------------------
                                              TOTAL         2004        2005-2006     2007-2008      THEREAFTER
                                              -----         ----        ---------     ---------      ----------
                                                                       ($ thousands)
<S>                                           <C>           <C>         <C>           <C>            <C>
Long-term debt obligations
Capital (Finance) Lease Obligations           245           190         55            -              -
Operating Lease Obligations                   10,773        1,089       2,373         2,428          4,884
Purchase Obligations                          -             -           -             -              -
Other Long-Term Liabilities Reflected on      -             -           -             -              -
the Company's Balance Sheet under GAAP
of the primary financial statements

         Total                                11,018        1,279       2,428         2,428          4,884
</TABLE>

IDENTIFICATION OF AUDIT COMMITTEE

     The Registrant has established an Audit Committee in accordance with
section 15 U.S.C. 78c(a)(58)(A). Each of the following directors serves on the
Audit Committee: Richard H. McCoy, Dr. Richard Bastiani, Michel Greco, Jon S.
Saxe, Dr. Brian J. Underdown, and Daniel A. Carriere. See the section entitled
"Committees of the Board of Directors - Audit Committee" in the Registrant's
Annual Information Form for the year ended December 31, 2003, which is filed as
Exhibit 1 to this Annual Report on Form 40-F.

UNDERTAKING AND CONSENT TO SERVICE OF PROCESS

     The Registrant undertakes to make available, in person or by telephone,
representatives to respond to inquiries made by the Commission staff, and to
furnish promptly, when required to do so by the Commission staff, information
relating to: the securities registered pursuant to Form 40-F; the securities in
relation to which the obligation to file an annual report on Form 40-F arises;
or transactions in said securities.

     A Form F-X signed by us and our agent for service of process is filed with
the Commission together with this Annual Report.

     Any change to the name and address of the agent for service for service of
process shall be communicated promptly to the Securities and Exchange Commission
by an amendment to the Form F-X.


                                         3

<PAGE>


                                   SIGNATURES

    Pursuant to the requirements of the Exchange Act, the Company certifies that
it meets all of the requirements for filing on Form 40-F, and has duly caused
this annual report to be signed on its behalf by the undersigned, thereto duly
authorized.

                                            ID BIOMEDICAL CORPORATION

                                            By: /s/ ANTHONY F. HOLLER
                                                -------------------------------
                                                Name:   Anthony F. Holler
                                                Title:  Chief Executive Officer

                               Date:   May 19, 2004


                                         4

<PAGE>


                                 CERTIFICATIONS

I, Anthony F. Holler, certify that:

1. I have reviewed this annual report on Form 40-F of ID Biomedical Corporation;

2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of
Registrant as of, and for, the periods presented in this annual report;

4. The Registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have:

         (a) designed such disclosure controls and procedures, or caused such
disclosure procedures to be designed under our supervision, to ensure that
material information relating to the Registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this annual report is being prepared;

         (b) evaluated the effectiveness of the Registrant's disclosure controls
and procedures as of a date within 90 days prior to the filing date of this
annual report (the "Evaluation Date"); and

         (c) presented in this annual report our conclusions about the
effectiveness of the disclosure controls and procedures based on our evaluation
as of the Evaluation Date;

5. The Registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the Registrant's auditors and the audit committee of
Registrant's board of directors (or persons performing the equivalent function):

         (a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the Registrant's ability to record,
process, summarize and report financial data and have identified for the
Registrant's auditors any material weaknesses in internal controls; and

         (b) any fraud, whether or not material, that involves management or
other employees who have a significant role in the Registrant's internal
controls.

6. The Registrant's other certifying officers and I have indicated in this
annual report whether there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Dated:  May 19, 2004

                                           By: /s/ ANTHONY F. HOLLER
                                               ---------------------------------
                                               Name:  Anthony F. Holler
                                               Title: Chief Executive Officer


                                         5

<PAGE>


I, Richard Bear, certify that:

1. I have reviewed this annual report on Form 40-F of ID Biomedical Corporation;

2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this annual
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of
Registrant as of, and for, the periods presented in this annual report;

4. The Registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Registrant and have:

         (a) designed such disclosure controls and procedures, or caused such
disclosure procedures to be designed under our supervision, to ensure that
material information relating to the Registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this annual report is being prepared;

         (b) evaluated the effectiveness of the Registrant's disclosure controls
and procedures as of a date within 90 days prior to the filing date of this
annual report (the "Evaluation Date"); and

         (c) presented in this annual report our conclusions about the
effectiveness of the disclosure controls and procedures based on our evaluation
as of the Evaluation Date;

5. The Registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the Registrant's auditors and the audit committee of
Registrant's board of directors (or persons performing the equivalent function):

         (a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the Registrant's ability to record,
process, summarize and report financial data and have identified for the
Registrant's auditors any material weaknesses in internal controls; and

         (b) any fraud, whether or not material, that involves management or
other employees who have a significant role in the Registrant's internal
controls.

6. The Registrant's other certifying officers and I have indicated in this
annual report whether there were significant changes in internal controls or in
other factors that could significantly affect internal controls subsequent to
the date of our most recent evaluation, including any corrective actions with
regard to significant deficiencies and material weaknesses.

Dated:  May 19, 2004

                                            By: /s/ RICHARD BEAR
                                                --------------------------------
                                            Name: Richard Bear
                                            Title: Principal Financial Officer


                                         6